274 related articles for article (PubMed ID: 28233412)
1. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.
Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A
Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412
[TBL] [Abstract][Full Text] [Related]
2. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
[TBL] [Abstract][Full Text] [Related]
3. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
[TBL] [Abstract][Full Text] [Related]
4. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
[TBL] [Abstract][Full Text] [Related]
5. Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging.
Angelov B; Angelova A; Drechsler M; Garamus VM; Mutafchieva R; Lesieur S
Soft Matter; 2015 May; 11(18):3686-92. PubMed ID: 25820228
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
7. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
[TBL] [Abstract][Full Text] [Related]
8. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
9. Metallo-Cubosomes: Zinc-Functionalized Cubic Nanoparticles for Therapeutic Nucleotide Delivery.
Tajik-Ahmadabad B; Chollet L; White J; Separovic F; Polyzos A
Mol Pharm; 2019 Mar; 16(3):978-986. PubMed ID: 30648870
[TBL] [Abstract][Full Text] [Related]
10. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
[TBL] [Abstract][Full Text] [Related]
11. Cuboplex-Mediated Nonviral Delivery of Functional siRNA to Chinese Hamster Ovary (CHO) Cells.
Sarkar S; Tran N; Soni SK; Nasa Z; Drummond CJ; Conn CE
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2336-2345. PubMed ID: 33410653
[TBL] [Abstract][Full Text] [Related]
12. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid.
Suzuki Y; Ishihara H
Int J Pharm; 2016 Aug; 510(1):350-8. PubMed ID: 27374199
[TBL] [Abstract][Full Text] [Related]
13. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
[TBL] [Abstract][Full Text] [Related]
14. The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions.
Shen HH; Crowston JG; Huber F; Saubern S; McLean KM; Hartley PG
Biomaterials; 2010 Dec; 31(36):9473-81. PubMed ID: 20880581
[TBL] [Abstract][Full Text] [Related]
15. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
16. Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.
Bruun J; Larsen TB; Jølck RI; Eliasen R; Holm R; Gjetting T; Andresen TL
Int J Nanomedicine; 2015; 10():5995-6008. PubMed ID: 26451106
[TBL] [Abstract][Full Text] [Related]
17. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
[TBL] [Abstract][Full Text] [Related]
18. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
Hashiba K; Sato Y; Harashima H
J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
[TBL] [Abstract][Full Text] [Related]
19. Correlating the Structure and Gene Silencing Activity of Oligonucleotide-Loaded Lipid Nanoparticles Using Small-Angle X-ray Scattering.
Hammel M; Fan Y; Sarode A; Byrnes AE; Zang N; Kou P; Nagapudi K; Leung D; Hoogenraad CC; Chen T; Yen CW; Hura GL
ACS Nano; 2023 Jun; 17(12):11454-11465. PubMed ID: 37279108
[TBL] [Abstract][Full Text] [Related]
20. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
